ArticleFood science and biotechnology2025
Validation and determination of steviol glycosides in processed food products.
Article in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Steviol Glycosides (E960) FromFood science & nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steviol glycosides have gained attention as low-calorie sweeteners. The acceptable daily intake (ADI) for steviol glycosides is 4 mg/kg bw/day, requiring continuous exposure assessments. To generate occurrence data for exposure evaluations, this study validated a high-sensitivity HPLC- variable wavelength detector (VWD) analytical method for quantifying five steviol glycosides and applied the method to processed food products distributed in South Korea. The limit of detection (LOD) was in the range of 0.2-0.5 mg/L, and the limit of quantification (LOQ) was in the range of 0.7-1.5 mg/L. The measurement uncertainty was evaluated to improve the reliability of the analytical results. Among the steviol glycosides analyzed, rebaudioside A and D were the most (96.8%) and least (11.7%) frequently detected compounds, respectively, in processed foods. All negative samples were confirmed by UHPLC-MS/MS analysis. The analytical method and monitoring results presented in this study are expected to contribute to prospective exposure assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.